Indaptus Therapeutics is trading 5.1% down at $2.40 today, appearing to track broader market volatility as the Nasdaq Composite declines 1.54%.
- The move follows a sharp regular-session drop from $2.82 to $2.53 on July 16, 2026, with the stock continuing to face downward pressure.
- There are no fresh company-specific headlines or earnings releases today, suggesting the price action is a continuation of recent volatility.